The effects of oral zinc sulphate during radiotherapy on anti-oxidant enzyme activities in patients with head and neck cancer: A prospective, randomised, placebo-controlled study

International Journal of Clinical Practice

Volumn 58, Issue 7, 2004, Pages 662-668

  Ertekin, Mustafa Vecdi ^a   Koc M ^a   Karslioglu I ^a   Sezen, O ^a   Taysi, S ^a   Bakan, N ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Activity of erythrocyte anti oxidant enzymes; Head and neck cancer; Radiotherapy; Zinc sulphate

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATALASE; COBALT; COPPER ZINC SUPEROXIDE DISMUTASE; ERYTHROCYTE ENZYME; GLUTATHIONE PEROXIDASE; PLACEBO; ZINC; ZINC SULFATE; ZINCO 220;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CANCER RADIOTHERAPY; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; COBALT TELETHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TIME; ZINC BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIOXIDANTS; CATALASE; COMBINED MODALITY THERAPY; FEMALE; GLUTATHIONE PEROXIDASE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RADIATION INJURIES; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; ZINC SULFATE;

EID: 4344647769     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.00006.x     Document Type: Article

References (43)

1. Agrawal A, Chandra D, Kale RK. Radiation induced oxidative stress: II studies in liver as a distant organ of tumor bearing mice. Mol Cell Biochem 2001; 224: 9-17.
2. Porock D. Factors influencing the severity of radiation skin and oral mucosal reactions: Development of a conceptual framework. Eur J Cancer Care 2002; 11: 33-43.
3. Sabitha KE, Shyamaladevi CS. Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy. Oral Oncol 1999; 35: 273-7.
4. Haboubi NY, El-Zammer O, O'Dwyer ST et al. Radiation bowel disease: Pathogenesis and management. Colorectal Dis 2000; 2: 322-9.
5. Demple B. Radical ideas: Genetic responses to oxidative stress. Clin Exp Pharmacol Physiol 1999; 26: 64-8.
6. Daukste A, Selga G, Vasilchenko I et al. Antioxidant status of the head and neck cancer oncological patients with references to nutritional requirement. Pathophysiology 1998; 5 (Suppl. 1): 182.
7. Lee HJ, Choi IY, Kil IS et al. Protective role of superoxide dismutases against ionizing radiation in yeast. Biochim Biophys Acta 2001; 1526: 191-8.
8. Riley PA. Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 1994; 65: 27-33.
9. Polar MF, Taysi S, Gul M et al. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct 2002; 20: 327-31.
10. Sun J, Chen Y, Li M, Ge Z. Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Biol Med 1998; 24: 586-93.
11. Abiaka C, Al-Awadi F, Al-Sayer H et al. Activities of erythrocyte antioxidant enzymes in cancer patients. J Clin Lab Anal 2002; 16: 167-71.
12. Troung-Tran AQ, Carter J, Ruffin R et al. New insights into the role of zinc in the respiratory epithelium. Immunol Cell Biol 2001; 79: 170-7.
13. Mocchegiani E, Muzzioli M, Giacconi R. Zinc metallothioneins, immune responses, survival and ageing. Biogerontology 2000; 1: 133-43.
14. Prasad AS, Kucuk O. Zinc in cancer prevention. Cancer Metastasis Rev 2002; 21: 291-5.
15. Ames BN. Micronutrients prevent cancer and delay aging. Toxicol Lett 1998; 102-3: 5-18.
16. Mocchegiani E, Giacconi R, Muzzioli M et al. Zinc, infections and immunosenescence. Mech Ageing Dev 2000; 12: 21-35.
17. Bagchi D, Bagchi M, Stohs SJ. Comparative in vitro oxygen radical scavenging ability of zinc methionine and selected zinc salts and antioxidants. Gen Pharmacol 1997; 28: 85-91.
18. Bagchi D, Vuchetich PJ, Bagchi M et al. Protective effects of zinc salts on TPA-induced hepatic and brain peroxidation, glutathione depletion, DNA damage and peritoneal macrophage activation in mice. Gen Pharmacol 1998; 30: 43-50.
19. Rostan EF, DeBuys HV, Madey DL et al. Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol 2002; 41: 606-11.
20. Bray TM, Bettger WJ. The physiological role of zinc as an antioxidant. Free Radic, Biol Med 1990; 8 (3): 281-91.
21. Guven M, Ozturk B, Sayal A et al. Lipid peroxidation and antioxidant system in the blood of patients with Hodgkin's disease. Clin Biochem 2000; 33: 209-12.
22. Aras NK, Nazlý A, Zhang W et al. Dietary intake of zinc and selenium in Turkey. J Radioanalyt Nuclear Chem 2001; 249: 33-7.
23. Aras NK, Olmez I. Human exposure to trace elements through diet. Nutrition 1995; 5 (Suppl. ): 506-11.
24. Ackurt F, Wetherilt H, Loker M et al. Biochemical assessment of nutritional status in pre- and post-natal Turkish women and outcome of pregnancy. Eur J Clin Nutr 1995; 49: 613-22.
25. Wetherilt H, Ackurt F, Brubacher G et al. Blood vitamin and mineral levels in 7-17 years old Turkish children. Int J Vitam Nutr Res 1992; 62: 21-9.
26. Doerr TD, Marks SC, Shamsa FH et al. Effect of zinc and nutritional status on clinical outcomes in head and neck cancer. Nutrition 1998; 14: 489-95.
27. Prasad AS, Kaplan J, Beck FW et al. Trace elements in head and neck cancer patients: Zinc status and immunologic functions. Otolaryngol Head Neck Surg 1997; 116: 624-9.
28. Rostkowska-Nadolska B, Pospiech L, Bochnia M. Content of trace elements in serum of patients with carcinoma of the larynx. Arch Immunol Ther Exp 1999; 47: 321-5.
29. Westin T, Ahlbom E, Johansson E et al. Circulating levels of selenium and zinc in relation to nutritional status in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1989; 115: 1079-82.
30. Brys M, Nawrocka AD, Miekos E et al. Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res 1997; 5: 145-52.
31. Liaw KY, Lee PH, Wu FC et al. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol 1997; 92: 2260-3.
32. Guven M, Ozturk B, Sayal A et al. Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis. Cancer Biochem Biophys 1999; 17: 155-62.
33. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 479-500.
34. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
35. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
36. Milne DB. Trace elements. In: Burris CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 2nd edn. WB Sounders Company, Philadelphia, USA 1986; 28: 1317-53.
37. Hsu HY, Lin SY, Huang CJ et al. Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy. Biol Trace Elem Res 1994; 46: 1-13.
38. Gonzales R, Auclair C, Voisin E et al. Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant diseases. Cancer Res 1984; 44: 4137-9.
39. Seven A, Civelek S, Inci E et al. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem 1999; 32: 369-73.
40. Mantovani G, Macciò A, Madeddu G et al. Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: Correlation with stage and performance status. Int J Cancer 2002; 98: 84-91.
41. Olszewski J, Zalewski P, Kedziora J et al. Evaluation of oxygen free radical generation and antioxidative enzymatic activity in blood of patients with carcinoma of the larynx (preliminary report). Otolaryngol Pol 2001; 55: 61-3.
42. Nagini S, Manoharan S, Ramachandran CR. Lipid peroxidation and antioxidants in oral squamous cell carcinoma. Clin Chim Acta 1998; 273: 95-8.
43. Weijl NI, Hopman GD, Wipkink-Bakker A et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998; 35: 273-7.